| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 453.611.773 $ | +106.560.317 $ | +30,9 % | 13 | 349.956.084 $ | +59.136.728 $ | +57,5 % | 9 | 250.235.851 $ | +60.746.423 $ | +25,9 % | 3 | ||||
| Roivant Sciences Ltd. | ROIV | → 0 | Schwach | 226.199.502 $ | +48.996.282 $ | +27,6 % | 1 | 177.203.220 $ | -11.619.180 $ | -6,2 % | 1 | 188.822.400 $ | +48.172.800 $ | +34,3 % | 1 |
| INSMED Inc | INSM | → 0 | Neutral | 25.754.400 $ | -20.714.280 $ | -44,6 % | 1 | 46.468.680 $ | -536.184 $ | -1,1 % | 1 | 47.004.864 $ | +10.895.232 $ | +30,2 % | 1 |
| ARGENX SE | ARGX | → 0 | Stark | 26.813.320 $ | +4.948.620 $ | +22,6 % | 1 | 21.864.700 $ | +10.432.520 $ | +91,3 % | 1 | ||||
| BeOne Medicines Ltd. | ONC | → 0 | Neutral | 23.918.558 $ | +2.860.879 $ | +13,6 % | 1 | 21.057.679 $ | +21.057.679 $ | 1 | |||||
| Mirum Pharmaceuticals, Inc. | MIRM | → 0 | Neutral | 21.247.400 $ | -2.345.491 $ | -9,9 % | 1 | 23.592.891 $ | +15.949.444 $ | +208,7 % | 1 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 22.940.040 $ | +11.666.987 $ | +103,5 % | 1 | ||||||||
| BELITE BIO, INC | BLTE | → 0 | Sehr stark | 18.604.097 $ | +18.604.097 $ | 1 | |||||||||
| Legend Biotech Corp | LEGN | → 0 | Schwach | 17.909.100 $ | +17.909.100 $ | 1 | |||||||||
| Abivax S.A. | ABVX | → 0 | Schwach | 13.500.631 $ | -4.029.869 $ | -23,0 % | 1 | 17.530.500 $ | +4.639.878 $ | +36,0 % | 1 | ||||
| NEKTAR THERAPEUTICS | NKTR | → 0 | Schwach | 15.109.500 $ | +15.109.500 $ | 1 | |||||||||
| Pharvaris N.V. | PHVS | → 0 | Neutral | 13.927.250 $ | -1.132.564 $ | -7,5 % | 1 | 15.059.814 $ | +6.442.558 $ | +74,8 % | 1 | ||||
| DBV Technologies S.A. | DBVT | → 0 | Neutral | 14.487.925 $ | +7.604.936 $ | +110,5 % | 1 | ||||||||
| EyePoint, Inc. | EYPT | → 0 | Sehr schwach | 14.250.600 $ | -157.987 $ | -1,1 % | 1 | 14.408.587 $ | +1.678.391 $ | +13,2 % | 1 | ||||
| Xenon Pharmaceuticals Inc. | XENE | → 0 | Neutral | 13.200.050 $ | +7.082.120 $ | +115,8 % | 1 | ||||||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 12.928.000 $ | +12.928.000 $ | 1 | ||||||||||
| 453.611.773 $ | +106.560.317 $ | +30,9 % | 13 | 349.956.084 $ | +59.136.728 $ | +57,5 % | 9 | 250.235.851 $ | +60.746.423 $ | +25,9 % | 3 | ||||